Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
批准号:
9029273
负责人:
MOLLY A HUGHES
金额:
$39.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-04-05 至 2017-07-31
关键词:
A/J MouseATP-Binding Cassette TransportersAnthrax diseaseAnti-Bacterial AgentsAntibioticsAntimicrobial Cationic PeptidesAntimicrobial EffectBacillus (bacterium)Bacillus anthracisBacillus anthracis sporeBacteriaBacterial ProteinsC57BL/6 MouseCXC ChemokinesCXC chemokine receptor 3CXCL10 geneCXCL11 geneCXCL9 geneCXCR3 geneCell divisionCellsChargeChemicalsCo-ImmunoprecipitationsDataDevelopmentElectron MicroscopyEscherichia coliExhibitsFoundationsFutureGenesGerminationGram-Negative BacteriaHealthHost DefenseHumanImmune responseImmune systemImmunofluorescence MicroscopyImmunoprecipitationIn VitroInfectionInfectious AgentIntegral Membrane ProteinInterferonsInvadedLeadLeukocytesLibrariesListeria monocytogenesLungLytA enzymeMediatingMulti-Drug ResistanceOrganismOutcomePhenotypePlasmidsPlayPredispositionProteinsPublishingRecombinantsRecruitment ActivityReportingReproduction sporesResistanceRoleSiteSite-Directed MutagenesisStagingTestingTherapeuticTherapeutic AgentsWorkantimicrobialbasechemokineconstrictioncrosslinkdrug resistant microorganismfightinggenetic approachin vivoinnovationinsightkillingsmacromoleculemicroorganismmigrationmouse modelmutantnovelpathogenreceptorresponsesmall molecule
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity Chemokines are chemotactic cytokines that function in host defense by orchestrating leukocyte migration to sites of infection. However, a number of chemokines have also been found to directly kill a range of pathogenic microorganisms through an as yet undefined mechanism. We previously reported that the interferon-inducible CXC chemokines, CXCL9, CXCL10, and CXCL11, block Bacillus anthracis spore germination, reduce spore viability, and kill vegetative cells, with CXCL10 being the most effective. We also reported that C57BL/6 mice, which are resistant to pulmonary B. anthracis Sterne strain infection, produced significant levels of CXCL9, CXCL10, and CXCL11 in their lungs following spore challenge; whereas, highly susceptible A/J mice did not generate significant levels of these chemokines during pulmonary infection. In vivo neutralization of CXCL9, CXCL9/CXCL10, or CXCL9/CXCL10/CXCL11 rendered C57BL/6 mice susceptible to pulmonary anthrax whereas neutralization of their shared receptor CXCR3, which is the receptor expressed on leukocytes recruited to the site of infection by CXCL9, CXCL10, CXCL11, had no impact on survival. These findings support that CXCL9, CXCL10, and CXCL11 have direct antimicrobial effects against B. anthracis both in vitro and in vivo. To identify the vegetative cell target(s) of CXCL10, we screened a B. anthracis transposon mutant library and found that disruption of ftsX, which encodes the transmembrane protein of a widely conserved prokaryotic ABC transporter, resulted in a CXCL10-resistant phenotype. Deletion of the ftsX gene in B. anthracis (i.e., DftsX) resulted in resistance of vegetative cells to CXCL10, and complementation of ftsX restored CXCL10 susceptibility. In contrast, DftsX spores remained susceptible to CXCL10, suggesting that spores have a different CXCL10 target. To further investigate the role of FtsX, as well as other B. anthracis targets of CXCL10, we propose three Specific Aims: 1) Determine the role of FtsX in susceptibility of vegetative cells to CXCL10; 2) Identify spore target(s) of CXCL10; and 3) Determine the role of spore and vegetative bacterial targets of CXCL10 during in vivo infection. These studies will provide a key foundation for the development of innovative therapeutic strategies for treating infections caused by not only B. anthracis but also a range of pathogenic, potentially multi-drug resistant microorganisms.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10468194
-
项目类别:
-
资助金额:$60.65万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10676878
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10120102
-
项目类别:
-
资助金额:$59.88万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
-
批准号:10269939
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2020
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8646871
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8822201
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
Bacillus anthracis Targets Involved in Chemokine-Mediated Antimicrobial Activity
-
批准号:8435665
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2013
-
负责人:MOLLY A HUGHES
-
依托单位:
2011 Chemical & Biological Terrorism Defense Gordon Research Conference (GRC) and
-
批准号:8052353
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2010
-
负责人:MOLLY A HUGHES
-
依托单位:
Innate Immune Recognition of B. anthracis
-
批准号:7530781
-
项目类别:
-
资助金额:$22.73万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
2009 Chemical and Biological Terrorism Defense Gordon Research Conference
-
批准号:7608881
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Innate Immune Recognition of B. anthracis
-
批准号:7633403
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2008
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6804467
-
项目类别:
-
资助金额:$26.62万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Studies on Macrophage Resistance to Anthrax Lethal Toxin
-
批准号:6676407
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2003
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6423015
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6770139
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
Identification of E. histolytica virulence factors
-
批准号:6603149
-
项目类别:
-
资助金额:$12.22万
-
财政年份:2002
-
负责人:MOLLY A HUGHES
-
依托单位:
海外基金